DGAP-PVR:
STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
|
DGAP Voting Rights Announcement: STADA Arzneimittel AG
STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
24.08.2017 / 18:38
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
|
2. Reason for notification
| |
Acquisition/disposal of shares with voting rights |
| X |
Acquisition/disposal of instruments |
| |
Change of breakdown of voting rights |
| |
Other reason:
|
3. Details of person subject to the notification obligation
| Name: |
City and country of registered office: |
| Bank of America Corporation |
Wilmington, DE
United States of America (USA) |
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:
6. Total positions
| |
% of voting rights attached to shares
(total of 7.a.) |
% of voting rights through instruments
(total of 7.b.1 + 7.b.2) |
total of both in %
(7.a. + 7.b.) |
total number of voting rights of issuer |
| Resulting situation |
0.82 % |
10.89 % |
11.71 % |
62,342,440 |
| Previous notification |
2.59 % |
9.48 % |
12.07 % |
/ |
7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
| ISIN |
absolute |
in % |
| |
direct
(Sec. 21 WpHG) |
indirect
(Sec. 22 WpHG) |
direct
(Sec. 21 WpHG) |
indirect
(Sec. 22 WpHG) |
| DE0007251803 |
0 |
512,736 |
0.00 % |
0.82 % |
| DE000A2GS5A4 |
|
180 |
0.00 % |
0.0003 % |
| Total |
512,916 |
0.82 % |
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Voting rights absolute |
Voting rights in % |
| Right of Use |
N/A |
N/A |
5,476,397 |
8.78 % |
| Right to Recall |
N/A |
N/A |
650,775 |
1.04 % |
| |
|
Total |
6,127,172 |
9.83 % |
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Cash or physical settlement |
Voting rights absolute |
Voting rights in % |
| Swaps |
15-Sep-2017 - 26-Aug-2019 |
N/A |
Cash |
661,463 |
1.06 % |
| |
|
|
Total |
661,463 |
1.06 % |
8. Information in relation to the person subject to the notification obligation| |
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). |
| X |
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name |
% of voting rights (if at least held 3% or more) |
% of voting rights through instruments (if at least held 5% or more) |
Total of both (if at least held 5% or more) |
| Bank of America Corporation |
% |
% |
% |
| NB Holdings Corporation |
% |
% |
% |
| Merrill Lynch International Incorporated |
% |
% |
% |
| BofAML Jersey Holdings Limited |
% |
% |
% |
| BofAML EMEA Holdings 1 Limited |
% |
% |
% |
| BofAML EMEA Holdings 2 Limited |
% |
% |
% |
| ML UK Capital Holdings Limited |
% |
% |
% |
| Merrill Lynch International |
% |
10.22 % |
11.04 % |
| |
|
|
|
| Bank of America Corporation |
% |
% |
% |
| NB Holdings Corporation |
% |
% |
% |
| BAC North America Holding Company |
% |
% |
% |
| BANA Holding Corporation |
% |
% |
% |
| Bank of America, National Association |
% |
% |
% |
| |
|
|
|
| Bank of America Corporation |
% |
% |
% |
| NB Holdings Corporation |
% |
% |
% |
| BAC North America Holding Company |
% |
% |
% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated |
% |
% |
% |
| Merrill Lynch Professional Clearing Corp. |
% |
% |
% |
| |
|
|
|
| Bank of America Corporation |
% |
% |
% |
| NB Holdings Corporation |
% |
% |
% |
| Merrill Lynch International Incorporated |
% |
% |
% |
| Merrill Lynch Group Holdings I, L.L.C. |
% |
% |
% |
| Merrill Lynch Equity Scotland Limited Partnership |
% |
% |
% |
| Merrill Lynch Equity S.a.r.l. |
% |
% |
% |
| |
|
|
|
| Bank of America Corporation |
% |
% |
% |
| NB Holdings Corporation |
% |
% |
% |
| BAC North America Holding Company |
% |
% |
% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated |
% |
% |
% |
9. In case of proxy voting according to Sec. 22 para. 3 WpHG| Date of general meeting: |
|
| Holding position after general meeting: |
% (equals voting rights) |
10. Other explanatory remarks:
24.08.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
STADA Arzneimittel AG |
|
Stadastraße 2-18 |
|
61118 Bad Vilbel |
|
Germany |
| Internet: |
www.stada.de |
| |
| End of News |
DGAP News Service |
603987 24.08.2017
Der finanzen.at Ratgeber für Aktien!
ETF-Sparplan